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Background: Osteoarthritis (OA) is a chronic degenerative disease of the articular cartilage, and its diagnosis is
based on symptoms and radiological signs that are only present in the late stages of the disease. Due to the limitations
in diagnosing OA before the onset of symptoms, such as pain, little is known about the molecular mechanisms involved
in the pathogenesis of OA. Experimental OA models are often used to study the kinetics of the progression of this
disease. In this report, we conducted a proteomic study of osteoarthritic cartilage during the early stages of OA using an
experimental rat model.
Results: Ten proteins that are differentially expressed under early OA conditions were identified by 2-DE and
MALDI-TOF/MS. These proteins mediated many processes, such as glycolysis and energy production (Nme2 and Pnp),
cartilage matrix (Col2a1), transcription and protein synthesis (Eef1a1 and DJ-1), signal transduction (CaM and Pebp1),
transport (Alb and Hba1), and latexin (Lxn). In addition, changes in Lxn expression in early OA were observed and
validated by western blot and immunofluorescence analysis.
Conclusions: The proteins that we identified indicate that energy metabolism, cartilage matrix remodelling, and
protective cellular mechanisms are associated with early OA. In addition, latexin expression during the early stages of OA
could be implicated in cartilage repair.
Keywords: Osteoarthritis, Cartilage, ProteomicsBackground
Osteoarthritis (OA) is a chronic degenerative joint disease
that is characterized by extracellular matrix (ECM) degrad-
ation and cell death, resulting in the gradual loss of articular
cartilage integrity [1-7]. In particular, certain ECM compo-
nents, such as collagen (types II, VI, and X), proteoglycans
(aggrecan, decorin, and lumican), and non-collagenous pro-
teins (annexin and fibronectin) are degraded during OA
pathogenesis, generating fragments that negatively regulate
metabolic processes in chondrocytes [8]. The failure of
chondrocytes to maintain a proper balance between the
synthesis and degradation of the ECM has been sug-
gested to result in cartilage degeneration during OA
pathogenesis [5,9-11].* Correspondence: fcazares@cinvestav.mx; bkouri@cinvestav.mx
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article, unless otherwise stated.However, little is known about the molecular mecha-
nisms involved in the early stages of OA due to the limi-
tations in detecting the early symptoms of the disease
before the onset of pain, which only manifests during
the late stages. The use of proteomic technologies then
allows the identification of novel biomarkers in tissues
and cells as indicators of normal and pathological pro-
cesses, such as OA [12-16]. Furthermore, these ap-
proaches are being applied to study the molecular basis
of OA etiology and the mechanisms that mediate cartil-
age regeneration and joint destruction in the later stages
of OA [16].
Previous works used two-dimensional electrophoresis
(2-DE) to identify certain proteins, such as the precursor
of collagens I and VI, annexin A1 (ANNX 1), and
phosphatidylethanolamine-binding protein 1 (Pebp1),
which were differentially expressed in chondrocytes from
healthy and osteoarthritic human cartilage [16]. How-
ever, these changes were observed only for proteins inntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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diagnosis of disease [16,17]. Thus, experimental OA
models are often used to study the kinetics of the pro-
cesses that mediate the development of OA [7].
Initially, our group generated a proteomic map of nor-
mal rat articular cartilage, in which the expression of
latexin (Lxn), a carboxypeptidase A inhibitor, was identi-
fied for the first time [18]. In this work, we performed a
proteomic study of osteoarthritic cartilage during the
early stages of an experimental OA rat model [7]. Ten
proteins were differentially expressed over time and
identified by MALDI-TOF/MS. Notably, Lxn was one of
the proteins that was modified early as detected in the
OA cartilage of rats.
Results and discussion
Our previous reports examined the histological and mo-
lecular changes of cartilage during OA pathogenesis in
an experimental animal model of OA, and showed that
our model can be evaluated according to Mankin’s histo-
logical grade parameters [2,5,7,19]. Twenty days after
induction, our rat OA animal model reproduces the
changes that occur in human cartilage in the late stages
of OA [20]; which including fibrillation the loss of tissue
cartilage mineralization and the formation of clusters
[5,7,21-25]. However, using our animal model also allows
OA kinetic changes to be followed starting in the early
stages of OA; including the initial fibrillation of the
cartilage surface area and superficial zone surrounding
chondrocytes and the initial formation of cell clusters.Figure 1 Macroscopic changes in the articular cartilage of rat during th
induced OA as viewed with a stereomicroscope. (A-C) Femoral condyles fromThese changes were observed after 5 days of OA induc-
tion [7,19,25]. Therefore and because these changes are
characteristic of early OA, we studied the changes in
the protein profile at 3, 5, and 10 days after the induc-
tion of OA.
Identification of early macroscopic changes in articular
cartilage of normal, sham, and OA-induced rats
The sham surgical procedure did not significantly change
the cartilage (Figure 1A-C): the tissues were smooth with a
shiny pink surface (Figure 1D-F). In contrast, the cartilage
from OA-induced animals underwent evident changes
starting 3 days after OA induction, showing an opaque ap-
pearance, rough surface, and a white colour in the affected
area, and these changes were more pronounced during OA
pathogenesis (right condyle) (Figure 1G-I). These results
demonstrate that a partial menisectomy and high-impact
exercise cause damage the articular cartilage morphology,
which causes joint deformity and induces OA.
Differential protein expression between normal and OA
cartilage during early stages in a rat model
The cartilage proteins were purified from the joints of rats
during the early experimental OA stage (normal, and OA
at 3, 5, and 10 days) and resolved by 2-DE; 280 ± 17 spots
were detected in the gels for each condition, and four spots
with equivalent expression in all samples were selected as
internal controls. The spots were consistent between dupli-
cates for each condition, indicating reproducibility. In OA-
induced cartilage, we observed 10 spots in the early OAe early stages of OA. Femoral condyles from normal, sham, and early
normal, (D-F) sham, and (G-I) OA-induced (OA 3, 5, and 10 days) rats.
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(Figure 2). Moreover, we observed patent differences in the
spot volumes between 3, 5, and 10 days after OA induction
(Figure 3).
The expressions of spot 1 (S1) and S2 increased and
peaked after at 3 days of OA induction compared with
the normal samples. In addition, S3, S7, and S8 were sig-
nificantly up-regulated after 5 days, whereas S4, S5, S9,
and S10 peaked at 10 days (Figure 3). The differences in
the spot intensity were quantified using the relative volume
percentage (vol%) and compared with the control values.
The images of the silver-stained gels were analysed using
ImageMaster 2D Platinum, version 7.0 (Tukey-Kramer
test, Table 1).Identification and functional classification of differentially
expressed proteins
The 10 differentially expressed proteins were excised,
digested, and identified by MALDI-TOF/MS. Table 1
shows the changes in the expression of these proteins on a
2-DE reference map (Additional file 1: Figure S1). Based
on their known functions, these proteins were classified
into 7 groups: glycolysis and energy production (Nme2
and Pnp), cartilage matrix (Col2a1), transcription and pro-
tein synthesis (DJ-1 and Eef1a1), signal transduction (CaM
and Pebp1), transport (Alb and Hba1), and latexin.Figure 2 Representative 2-DE proteomic profiles of normal and OA ca
were resolved on IPG strips at pH 3–10 NL using an SDS-PAGE gradient (5-
(B) OA 3 days. (C) OA 5 days. (D) OA 10 days. The selected spots are numbTwo proteins mediated metabolism and energy pro-
duction (Pnp and Nme2) [26,27]. Pnp has been impli-
cated in purine metabolism, and its expression is linked
to the accumulation of toxic levels of deoxyguanosine
triphosphate (dGTP) which induces apoptosis in T lym-
phocytes [28]. Nme2 catalyses the transfer of terminal
phosphate groups of nucleoside 5′-triphosphate to nu-
cleoside 5′-diphosphate, which mediates the biosynthesis
of ribo- and deoxyribonucleoside triphosphates, except
ATP [27]; it also regulates a wide range of cellular func-
tions, including proliferation, differentiation, and neoplas-
tic transformation [29]. The increase in both proteins
during early OA could implicate them in metabolic and
purine salvage pathways as a consequence of the increase
in catabolism during OA pathogenesis.
Type II collagen is the principal component of articular
cartilage and comprises its basic architecture, and it is the
chief constituent of collagens [30,31]. However, in the late
stages of OA, type II collagen is substituted by other colla-
gens, such as types I and X, due to the catabolic activity of
chondrocytes [16,32]. Our results showed that the type II
collagen levels increased 3 and 5 days after OA induction,
which might be related to a reparative cartilage phase.
This positive regulation during OA might be a self-
protective response of chondrocytes to changes in the
pericellular environment that wane during at later stages
[11,16,28,31,32].rtilage during the early stages (3, 5, and 10 days). The proteins
20%). The gels were silver-stained. (A) Profiles from normal conditions.
ered and marked with red circles.
Figure 3 Differentially expressed proteins during early OA by 2-DE and MALDI-TOF/MS. Ten proteins were differentially expressed during
the early stages of OA (3, 5, and 10 days), compared with normal levels (see Table 1).
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involved in ECM remodelling via MMP-1, MMP-3, and
MMP-13 activation [33], such as Pebp1 and CaM, are
also up regulated during the early stages of OA. Pebp1 is
a Raf kinase inhibitor that has been identified in the
proteome of normal human articular cartilage, whereas
it has shown decreased expression in the late stages of
OA [8,16,18]. Our results suggested that Pebp1 partici-
pates in ECM remodelling during early OA, possibly via
the regulation of downstream signalling pathways.
CaM regulates signal transduction, forming calcium-
calmodulin complex- dependent protein kinase II (CaMKII)[34]. In addition, the CaMKII complex has been implicated
as a signalling receptor for acid-N-methyl-D-aspartate
(NMDA) and is activated as part of the mechanotransduc-
tion response of normal human articular chondrocytes to
mechanical stimulation. However, this route is not activated
after stimulation in OA chondrocytes [35]. Thus, the dys-
regulation of CaMKII signaling has been suggested to be
significant for the onset and progression of OA.
In addition, DJ-1 and Eef1α1 were identified as proteins
that mediate the transcription and synthesis of others
proteins. DJ-1 has several functions, such as protection
against oxidative stress and cell death [36]. Furthermore,











Match Scoref) Proteins expression compared with
Normal samples (% increase)g)Protein Pept.
OA 3 days OA 5 days OA 10 days
Extracellular Matrix
S1 Col2α1 Collagen alpha-1 (II) chain precursor P05539 38/8.46 30-32/6.6-6.7 12 16 84 22 15 12
Transcription, protein
synthesis
S2 Eef1α1 Elongation factor 1-alpha 1 P62630 50.11/9.1 50.11/9.1 32 13 37 499 407 314
S3 DJ-1 Protein DJ-1 88767 19.9/6.32 19.9/6.3 54 9 85 138 313 271
Glycolysis and energy production
S4 Nme2 Nucleoside diphosphate kinase P19804 17.28/6.9 17.3/6.9 87 16 187 127 515 700
S5 Pnp Purine nucleoside phosphorylase P85973 32.3/6.46 32.32/6.4-6.5 43 8 49 243 277 384
Signal transduction
S6 CaM Calmodulin P62161 16.7/4.09 16.8/5.47 63 8 101 124 130 185
S7 Pebp1 Phosphatidylethanolamine binding protein 1 P31044 20.6/5.48 17.18/4.9-5.5 52 7 76 54 92 29
Transport
S8 Alb Serum albumin (n-terminal fragment) P02770 65.9/5.8 68.6/6.09 24 12 105 435 853 568
S9 Hba1 Haemoglobin subunit alpha-1/2 P01946 15.1/7.93 19.7/6.32 69 6 88 231 157 284
Others
S10 Lxn Latexin Q64361 25.5/5.77 25/5.8 48 11 118 20 29 54
a)Spot number as indicated in Figure 2.
b)Protein name and accession number according UniprotKB/Swiss-prot database of Rattus norvegicus species.
c)Theoretical Mr and pI according to protein sequence.
d)Experimental Mr and pI calculated by analysis of the gel image with ImageMaster 2D Platinum 7.0 software.
e)Sequence coverage for identified protein (peptide confidence ≥95) in relation on the full sequence.
f)The Score value listed within the Query table is the Ion Score. Ion score is −10*Log (P), where P is the probability that the observed match is random event.

















Figure 4 (See legend on next page.)
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Figure 4 Expression and localization of Lxn in normal articular cartilage during the early stages of OA in a rat model. (A) Positive
control and phase contrast microscopy for Lxn expression in rat heart tissue. (B) Negative control for Lxn expression in rat heart tissue. (C) Number of
pixels, expressed as area of Lxn in the total cartilage. (D) Expression of Lxn in the 3 zones (SZ, MZ, and DZ) in normal and osteoarthritic cartilage.
(E, G, I, and K) Lxn expression in normal articular cartilage and OA at 3, 5, and 10 days (F, H, J, and L), perinuclear and cytoplasmic localization of Lxn
in normal articular cartilage and OA at 3, 5, and 10 days (amplification of panel E, G, I, and K). (M) Representative western blot of Lxn expression in
normal and OA cartilage during early stages (3, 5, and 10 days). The densitometry graph shows the protein levels of Lxn measured by optical density
(OD) normalized to β-actin. The results show the means ± S.E.M. of 3 independent experiments using a Tukey-Kramer multiple comparison test.
Significant differences are represented by asterisks (*p < 0.05, **p < 0.01, ***p < 0.001).
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chondrocyte apoptosis induced by reactive oxygen species
(ROS) has been considered important in OA pathogenesis
[39,40]. Our results have demonstrated that DJ-1 is up-
regulated in the early stages of OA, which suggested its
involvement in the regeneration of cartilage due to the
prevention chondrocyte death via the removal of ROS.
Eef1α1 is involved in translation [41] and also increases in
expression, indicating that chondrocytes up-regulate
translation machinery during early OA to synthesize
proteins and repair damaged cartilage [5,10].
Hba1 and Alb, which mediate oxygen transport and
osmotic pressure, have been previously detected in car-
tilage. Both proteins were up-regulated but their func-
tions in OA cartilage remain unknown [8,18].
Latexin (Lxn), a carboxypeptidase A inhibitor, was up-
regulated during early OA. The expression of this pro-
tein has previously been reported in rat cartilage [18],
thus, we focused on latexin analysis.
Differential expression of Lxn in early OA-induced cartilage
in rats
A previous study reported Lxn expression in the articu-
lar cartilage [18] of rats. Lxn mediates the development
of skeletogenesis and the growth plate [42]. The increase
in the rise Lxn levels during early OA found by the
proteomic analysis suggests that it mediates OA patho-
genesis. Thus, we examined Lxn with a proteomic ana-
lysis to validate these results during early OA. We
utilized immunofluorescence and WB to analyse its ex-
pression and localization in articular cartilage. Because
we have previously observed that the normal and sham
controls are similar [19,22] we only used the normal
control for the validation experiments. Figure 4 shows the
positive and negative controls for Lxn in rat heart tissue
(A and B). In addition, Figure 4A includes phase contrast
microscopy to show the Lxn localization in the tissue.
In normal rat articular cartilage, Lxn is primarily
expressed in the chondrocytes of 3 cartilage zones—the
surface zone (SZ), middle zone (MZ), and deep zone
(DZ)—at all time points (Figure 4E, G, I, and K). The
Lxn levels were higher in osteoarthritic cartilage 5 and
10 days after OA was induced (Figure 4C and D). The
distribution of Lxn, was granular in the cytoplasm ofmost chondrocytes and arranged in the perinuclear MZ
and DZ in some chondrocytes (Figure 4F, H, J, and L).
The expression of Lxn was also analysed by WB under
normal conditions and during early OA. As shown in
Figure 4M, the expression of Lxn was up regulated after
3 days and maximized 10 days after OA induction com-
pared to normal cartilage. These data corroborated our
2-DE findings, which validated the use of these tools to
examine the differential expression of proteins during
early OA.
The expression of Lxn was also analysed by WB under
normal conditions and during early OA. As shown in
Figure 4M, Lxn was up-regulated 149% from the normal
cartilage level after 3 days, and this increase reached
215% and 207% after 5 and 10 days, respectively. These
data corroborated our 2-DE findings, which validated
the use of these tools to examine the differential expres-
sion of proteins during early OA; when Lxn was up-
regulated 20% after 3 days, 29% after 5 days, and 54%
after 10 days of OA induction. The increases observed
by WB were more pronounced that those observed by
2-DE, likely due to antibody specificity.
The expression of Latexin (Lxn), an inhibitor of car-
boxipeptidase A, was increased during the early stages
of OA, which suggested that it acted as a regulator of
carboxypeptidase activity. This effect may have reduced
the ability of these enzymes to bind to substrates, which
inhibited degradation. This protective mechanism of the
chondrocytes might prevent mechanical damage to car-
tilage which is involved in the development of OA. Lxn
might also participate in other cartilage repair processes,
such as the proliferation of chondrocytes and cartilage
regeneration, in response to the damage that is incurred
during early OA [42,43]. Recently, Lxn was reported to
be localized in the nuclei and cytoplasm of proliferating
and prehypertrophic chondrocytes during skeletogenesis
and skeletal regeneration [42]. Latexin was also identi-
fied as negative regulator of stem cell replication and in-
creased apoptosis [44]. Previous works have shown that
chondrocytes in the cartilage of older people remain in a
resting phase of the cell cycle, which limits their poten-
tial for growth. This arrest has also been associated with
changes in telomere length [45]. Thus, Lxn may govern
senescence mechanisms in chondrocytes [1].
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The rat model of induced osteoarthritis has allowed us
to demonstrate the differential expression of proteins
during the early stages of OA with a proteomic analysis.
The changes in the expression of some proteins during
the early stages of OA suggested its participation in the
reparative phase of the cartilage because most of the
identified proteins were involved in various reparative
cell processes such as the remodelling of the ECM, en-
ergy metabolism, and protective cellular mechanisms.
In addition, this study examined the expression and im-
munolocalization of Lxn, which appeared to play a role in
the cartilage repair phase of early OA as an inhibitor of
degradative enzymes. Although additional work is re-
quired to understand the relationship between these pro-
teins and early cartilage injury, our results have enabled us
to identified novel proteins involved in the start of OA
pathogenesis, which could guide the discovery of bio-
markers for this disease in humans.
Materials and methods
Tissue sampling
Cartilage samples were obtained from the knees of 159
normal male Wistar rats (130–150 g) and 1017 rats with
OA that were induced by partial menisectomy of the
right hind leg, followed by high-impact exercises 3, 5,
and 10 days after OA induction (early OA). This proced-
ure has been described elsewhere [2,5,7,19] and shown
to reproduce the cartilage changes observed during the
late stages of human OA 20 days after OA induction in
rats [20]. These changes include fibrillation, a loss of tis-
sue, cartilage mineralization and the formation of clus-
ters [5,7]. Cartilage samples were also obtained from 240
sham rats (incision without menisectomy or exercises).
All procedures involving animals were approved by our
institutional committee (CICUAL-Cinvestav-IPN) and
performed following the animal facility regulations and
Mexican official regulatory Guideline for the Care and
Use of Laboratory Animals; NOM-069-ZOO-1999.
Protein extraction and preparation
A pool of cartilage samples from the knees of 30 normal
rats, 120 sham rats, and 120 rats with conditionally in-
duced OA (3, 5, and 10 days after OA induction) were used
by independent experiment. The proteins were extracted
based on selective extraction as reported by Vincourt [13]
with some modification [18]. Briefly, samples were frozen
in liquid nitrogen, mechanically pulverized, suspended in
extraction buffer [500 mM NaCl, 50 mM HEPES pH 7.2,
complete protease inhibitor cocktail, (Roche Applied
Science) and homogenized. In addition, the samples
were sonicated (POLYTRON® PT 2100) (10 strokes at
15,000 × g) and then stored overnight at 4°C. The insol-
uble material was then removed by centrifugation (6,000 ×g, at 4°C for 7 min), the supernatant was recovered, and
cetylpyridinium chloride (CPC) 1% (w/v) was added to re-
move proteoglycans (PGs) followed by another centrifuga-
tion (6,000 × g, at 4°C for 7 min) [46]. To remove the
lipids and salts, the supernatant was precipitated with
methanol (400 μL methanol/100 μL sample) and centri-
fuged (14,000 × g, for 30 min), and the liquid phase was
removed. This procedure was repeated twice. The pellet
was resuspended in 2-DE sample buffer [7 M urea, 2 M
thiourea, 4% (w/v) CHAPS, 2% (v/v) immobilized pH gra-
dient (IPG) buffer, pH 3–10 (GE Healthcare Life Sciences,
Sweden) and 40 mM dithiothreitol (DTT)] and supple-
mented with protease inhibitors [13,14]. In addition, the
2D Clean-Up Kit (GE Healthcare) was used for selective
protein precipitation and cleaning. The precipitate was re-
suspended in rehydration solution [7 M urea, 2 M thio-
urea, 2% (w/v) CHAPS, 0.5% (v/v) IPG buffer, pH 3–10,
and 154 mM DTT, and 0.001% bromophenol blue] sup-
plemented with protease inhibitors. The protein concen-
tration was measured with a Bradford assay [19]. All
experiments were performed in independent duplicates.
Two-dimensional electrophoresis (2-DE)
Protein extract (300 μg) resuspended in rehydration
solution (250 μL) was used to rehydrate Immobiline
DryStrip gels (IPG strips) that were 13 cm in size (GE,
Healthcare) at pH 3–10 NL for 12 h at room temperature.
Electrofocusing was performed in an Ettan IPGphor 3
(GE Healthcare, USA) per the manufacturer’s protocols.
The disulphide bonds in proteins were reduced and
alkylated using DTT and iodacetamide, respectively.
The proteins were silver-stained immediately after to
the second-dimension run on an SDS-PAGE gradient
(5–20%) [18]. These experiments were performed in
duplicate, and technical replicas (data not shown) were
only implemented for controls.
Image acquisition and data analysis
Digital images of 2-DE gels were obtained using an
ImageQuant LAS 4000 System (GE Healthcare) and
analysed using ImageMaster 2D Platinum, version 7.0
(GE Healthcare Life Sciences, Switzerland) to measure the
protein expression levels. The spots were counted and
compared automatically with subsequent manual correc-
tion. For the semiquantitative comparison, the optical dens-
ities were automatically detected; the spots were selected,
the confidence interval for the difference between two
means was obtained (data not shown) and analysed with a
Tukey-Kramer multiple comparison test with at p ±0.001.
Spot excision and trypsin digestion
The spots were processed after excision. The samples
were dehydrated by incubation in 100 μL acetonitrile for
5 min at room temperature. The supernatant was then
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The peptides were digested as previously reported [47].
Briefly, dry polyacrylamide pieces were prepared for in-
gel digestion with 0.020 μg modified trypsin (sequen-
cing-grade, Roche Molecular Biochemicals) overnight at
37°C. The resulting peptides were extracted twice with
ACN/TFA solution [50% w/v acetonitrile (ACN)/% w/v
trifluoroacetic acid (TFA)], incubated for 10 min at room
temperature and centrifuged at 14,000 × g for 30 sec. The
peptide extracts were combined and reduced/desalted
using C18-ZipTips (Millipore Corporation, Bedford, MA,
USA).
Mass spectrometry by MALDI
The resulting peptide extracts were analysed by
MALDI-TOF/MS with a Voyager DE Pro mass spec-
trometer in the linear mode (Applied Biosystems) at
the Protein Core Facility, Columbia University Medical
Center, New York, USA. To identify the proteins by
PMF, the molecular mass of each tryptic fragment was
searched against the National Center for Biotechnology
Rattus norvegicus database using the MASCOT program
(http://www.matrixscience.com). A confidence interval
≥99% was used to identify the proteins (Unused ProtScore
> 2.0). The possible oxidation of methionine residues, and
carbamidomethylation at cysteine residues as variable
modifications were considered. A maximum of one missed
tryptic cleavage per protein was allowed in the database
search. A mass accuracy of 100 ppm was used for MS. For
positive identifications, a MASCOT score > 56 was con-
sidered significant (p < 0.05).
Western blot
The cartilage samples of normal and OA-induced rats
(3, 5, and 10 days) were frozen in liquid nitrogen, mech-
anically pulverized, suspended in lysis buffer (25 mM
Tris–HCl, pH 7.6, 150 mM NaCl, 1% NP-40, 1% sodium
deoxycholate, 0.1 % SDS) with complete protease inhibitor
cocktail, and homogenized in a polytron tissue grinder
(POLYTRON® PT 2100). The samples were shaken for 2 h
at 4°C and clarified by centrifugation at 10,000 × g at 4°C
for 5 min. The protein concentration was measured with a
Bradford assay. Subsequently, the obtained samples were
dissolved in Laemmli buffer (which contained 1% SDS
and β-mercaptoethanol) and boiled for 5 min. SDS-PAGE
was performed using 5–20% gradient gels of 7 cm and
80 μg of protein per lane, after which the proteins were
transferred onto nitrocellulose membranes by wet transfer
at 350 mA for 2.5 h.
The membranes were blocked with 5% non-fat dry
milk in Tris-buffered saline (TBS), pH 7.5, containing
0.1% Tween 20 (TBS-T) for 2 h at 37°C with gentle shak-
ing and incubated overnight at 4°C with rabbit polyclonal
anti-Lxn (1:1000; sc-47089, Santa Cruz Biotechnology,Santa Cruz, CA, USA). Peroxidase-conjugated goat
anti-rabbit was used as the secondary antibody (1:40,000;
Jackson Immunoresearch Laboratories Inc. West Grove,
PA, USA) for 2 h at room temperature. These experiments
were performed in triplicate.Immunonofluorescence (IF)
To analyse the macroscopic characteristics of articular
cartilage, femoral condyles were obtained from normal
and OA-induced rats (3, 5, and 10 days) and observed under
a stereomicroscope (E2 4D Leica, Heidelberg, Germany).
The cartilage samples were then cryopreserved with
10% PBS-sucrose for 24 h, cryosectioned (Leica CM
1100; Heerbrugg, Switzerland), mounted on gelatine-
coated slides, and stored at −20°C for 2 days. The sam-
ples were hydrated in PBS, treated with 0.2% Tween 20
in PBS for 10 min, and preincubated with 0.2% IgG-free
bovine serum albumin (Sigma Chemical, Germany) for
20 min at room temperature. The sections were incu-
bated overnight at 4°C with anti-Lxn goat polyclonal
antibody (1:70, sc-47089, Santa Cruz Biotechnology,
Santa Cruz, CA, USA) followed by incubation with
fluorescein isothiocyanate (FITC)-tagged anti-goat IgG
(1:50 Zymed Laboratories, South San Francisco, CA) for
1 h at room temperature. The nuclei were counterstained
with propidium iodide for 1 min (1:3000; Vector Labora-
tories, Burlingame, CA), and the samples were mounted
with Vectashield. As a negative control, the primary anti-
body was omitted. Rat heart tissue was used as a positive
control. The sections were analysed with confocal micros-
copy (TCP-SP2, Leica, Heidelberg, Germany). These ex-
periments were performed in triplicate.Statistical analysis
A statistical analysis was performed using pools of 30 rats
by condition (normal, and 3, 5 and 10 days of OA induc-
tion) for western blot in three independent assays. The
immunoreactions were visualized by chemiluminescence
(ECL Plus western blotting detection system, GE Health-
care, Buckinghamshire, UK); the band intensities obtained
from the western blot assays were quantified by optical
densitometry. The relative intensity was expressed in arbi-
trary optical density units (OD). In all cases the statistical
analysis was performed using a Tukey-Kramer multiple
comparison test. Three rats were used for each condition
for IF. Three sections were obtained from each rat. In
each rat, 3 sections and 3 fields were randomly selected
and analised; this procedure was performed in triplicate.
The Leica LAS AF Lite confocal program was used to
quantify the immunolabelling, wherein the fluorescence
intensities were measured in each zone based on the num-
ber of pixels per area.
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Additional file 1: Figure S1. Representative 2-DE proteomic maps of
identified proteins in OA cartilage during early stages (3, 5, and 10 days).
(A-B) Samples of OA cartilage at 3 days (duplicate experiment). Proteins
were resolved on IPG strips pH 3–10 NL (5-20% SDS-PAGE gradient gels,
gels were silver-stained). The spots were marked with arrowheads according
to the database [UniProt Knowledge base (UniProtKB)/Swiss-Prot] for Rattus
norvegicus species.
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